Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FARMACEU
Faes Farma SA
Original Assignee
FARMACEU
Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FARMACEU, Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SAfiledCriticalFARMACEU
Priority to ES394406ApriorityCriticalpatent/ES394406A1/en
Publication of ES394406A1publicationCriticalpatent/ES394406A1/en
A process for obtaining the lithium salt of gammaaminobetahydroxybutyric acid, characterized in that said acid is reacted in aqueous medium, at room temperature and outside the contact of air, with the lithium hydroxide. (Machine-translation by Google Translate, not legally binding)
ES394406A1971-08-211971-08-21A procedure to obtain lithium salt. (Machine-translation by Google Translate, not legally binding)
ExpiredES394406A1
(en)
A procedure for the preparation of (3-trifluormethylphenoxy) - (4-chlorophenyl) acetate of 2-acetamidoetilo. (Machine-translation by Google Translate, not legally binding)
Procedure for the preparation of alpha-escina by isomerization of beta-escina in aqueous solution. (Machine-translation by Google Translate, not legally binding)